A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä

Enhanced Antibody Production in Clever-1/Stabilin-1-Deficient Mice




TekijätDunkel J, Viitala M, Karikoski M, Rantakari P, Virtakoivu R, Elima K, Hollmen M, Jalkanen S, Salmi M

KustantajaFRONTIERS MEDIA SA

Julkaisuvuosi2018

JournalFrontiers in Immunology

Tietokannassa oleva lehden nimiFRONTIERS IN IMMUNOLOGY

Lehden akronyymiFRONT IMMUNOL

Artikkelin numeroARTN 2257

Vuosikerta9

Sivujen määrä11

ISSN1664-3224

DOIhttps://doi.org/10.3389/fimmu.2018.02257

Rinnakkaistallenteen osoitehttps://research.utu.fi/converis/portal/detail/Publication/36033486


Tiivistelmä
Clever-1, encoded by the Stab1 gene, is a scavenger and leukocyte trafficking receptor expressed by subsets of vascular and lymphatic endothelial cells and immunosuppressive macrophages. Monocyte Clever-1 also modulates T cell activation. However, nothing is known about the possible links between B cell function and Clever-1. Here, we found that Stab1 knockout mice (Stab1(-/-)) lacking the Clever-1 protein from all cells present with abnormally high antibody levels under resting conditions and show enhanced humoral immune responses after immunization with protein and carbohydrate antigens. Removal of the spleen does not abolish the augmented basal and post-immunization antibody levels in Clever-1-deficient mice. The increased IgG production is also present in mice in which Clever-1 is selectively ablated from macrophages. When compared to wildtype macrophages, Clever-1-deficient macrophages show increased TNF-alpha synthesis. In co-culture experiments, monocytes/macrophages deficient of Clever-1 support higher IgM production by B cells, which is blocked by TNF-alpha depletion. Collectively, our data show that the excessive inflammatory activity of monocytes/macrophages in the absence of Clever-1 results in augmented humoral immune responses in vivo.

Ladattava julkaisu

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.





Last updated on 2024-26-11 at 19:29